Side effects of frequently used oral antidiabetics on wound healing in vitro
- 99 Downloads
Lifestyle diseases such as diabetes and arteriosclerosis are rising in the increasingly aging society, and the number of patients with daily intake of glucose-lowering medication has also increased. Interestingly, knowledge about oral antidiabetics with regard to wound healing is scarce. Therefore, the aim of this study was to identify possible (side) effects of the most frequently prescribed oral antidiabetics on skin cells and wound healing. Four oral antidiabetics of different substance classes (i.e., metformin, glibenclamide, sitagliptin, repaglinide) were investigated with regard to the promotion of cell metabolism and migration of human skin fibroblasts and keratinocytes by XTT and scratch assays. In addition, histological and immunohistochemical analyses were performed in a 3D wound model to address the impact of the antidiabetics on regeneration processes, such as cell migration, fibroblast activity, epidermal thickness, and cell apoptosis. In comparison to systemic application, metformin displayed the most adverse effects in vitro in nearly all analyses, interestingly at serum equivalent concentrations. In contrast, sitagliptin and glibenclamide had a slight but insignificant effect on fibroblasts compared with keratinocytes. Repaglinide tended to have a negative influence on keratinocyte metabolism. Interestingly, antidiabetics generally induced a significantly enhanced rate of apoptosis in fibroblasts, with the exception of repaglinide.
Antidiabetics influenced key players in wound healing, namely, keratinocytes and fibroblasts. Particularly, metformin impaired human skin cells. These findings should be kept in mind in further studies because of their putative relevance in patients suffering from chronic wounds that do not respond to various wound therapies.
KeywordsWound healing Antidiabetics Metformin Sulfonylurea Dipeptidylpeptidase inhibitors 3D wound healing model
EKS and ALS designed the study. NT, ALS, MB, and VK carried out the experiments; EKS analyzed the results, performed the statistical analysis, and generated the figures; HSB focused on the pharmacological background; ALS, MB, and EKS drafted the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- AbZ-Pharma (2004) Summary of product characteristics. AbZ-Pharma GmbH, UlmGoogle Scholar
- AbZ-Pharma (2016) Summary of product characteristics. AbZ-Pharma GmbH, UlmGoogle Scholar
- Amin S, Lux A, O'Callaghan F (2018) The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.13780
- Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH (2012) Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res (Phila) 5:355–364CrossRefGoogle Scholar
- Besser M, Khosravani M, Severing AL, Rembe JD, Stuermer EK (2017) Acute and chronic wound fluid inversely influence wound healing in an in-vitro 3D wound model. Journal of Tissue Repair and Regeneration 1(1):1–11Google Scholar
- Bundesausschuss G (2016) G-BA setzt verordnungseinschränkung für Glinide in KraftGoogle Scholar
- Grandt D (2016) Barmer Arzneimittel Report 2016. Barmer-GEK-Arzneimittel-Report : Auswertungsergebnisse der Barmer-GEK-Arzneimitteldaten aus den Jahren 39: 245Google Scholar
- Kaindl T, Kloosterman C (2008) Summary of product characteristics Sandoz pharmaceuticals GmbH, Sandoz pharmaceuticals, DocCode 7215194_7215195–1311–967-03Google Scholar
- Lee YW, Tung TH, Gomez S, Lo CM (2016) Mitochondrial respiration regulates proliferation, micromotion, and wound healing migration of human mesenchymal stem cells. FASEB J 30:1300.1310–1300.1310Google Scholar
- Marfella R, Sasso FC, Rizzo MR, Paolisso P, Barbieri M, Padovano V, Carbonara O, Gualdiero P, Petronella P, Ferraraccio F, Petrella A, Canonico R, Campitiello F, Della Corte A, Paolisso G, Canonico S (2012) Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. Exp Diabetes Res 2012:892706CrossRefGoogle Scholar
- MSD (2016) Summary of product characteristics. MSD SHARP & DOHME GMBH, HaarGoogle Scholar
- Nguyen KD, Lee DA (1992) Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. Invest Ophthalmol Vis Sci 33:2693–2701Google Scholar
- Ochoa-Gonzalez F, Cervantes-Villagrana AR, Fernandez-Ruiz JC, Nava-Ramirez HS, Hernandez-Correa AC, Enciso-Moreno JA, Castañeda-Delgado JE (2016) Metformin induces cell cycle arrest, reduced proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS One 11:e0150900CrossRefGoogle Scholar
- Surazyński A, Pałka J, Wołczyński S (2004) Acetylsalicylic acid-dependent inhibition of collagen biosynthesis and beta1-integrin signaling in cultured fibroblasts. Med Sci Monit 10:BR175–BR179Google Scholar